LAVANYA NAGINENI
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology NASHVILLE, TN NPI 1699986943
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology TN UCB, Inc. All categories
General Payments — all program years on this page
$27,593.79
- Category: General Payments
- Program years: PY2018–2024
- Record count: 1,072
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $861.73 across 38 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $861.73 | 38 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $154.92 | 5 |
| Neurocrine BioSciences, Inc. | $119.19 | 4 |
| PFIZER INC. | $75.56 | 4 |
| ABBVIE INC. | $70.71 | 3 |
| Alexion Pharmaceuticals, Inc. | $56.27 | 3 |
| Teva Pharmaceuticals USA, Inc. | $49.85 | 3 |
| EISAI INC. | $39.35 | 2 |
| Amgen Inc. | $31.22 | 1 |
| Neurelis, Inc. | $30.14 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $27.66 | 1 |
| ARGENX US, INC. | $27.60 | 1 |
| Amneal Pharmaceuticals LLC | $25.61 | 1 |
| ACADIA Pharmaceuticals Inc | $23.90 | 1 |
| Biogen, Inc. | $23.85 | 1 |
| Lundbeck LLC | $21.93 | 1 |
| Medtronic, Inc. | $20.94 | 1 |
| Lilly USA, LLC | $18.39 | 1 |
| CATALYST PHARMACEUTICALS, INC. | $16.86 | 1 |
| Alkermes, Inc. | $14.47 | 1 |
| Janssen Pharmaceuticals, Inc | $13.31 | 1 |
By program year
Records — PY2024 (38)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.